Behrenbruch Christian bought TLX
April 29, 2026 · Form 4 insider transaction
Behrenbruch Christian bought 33,435 shares of Telix Pharmaceuticals Limited at $14.87 per share, a transaction worth $497.2K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 7 days after the transaction.
Footnotes
The purchase prices are reported in Australian Dollars.; The price reported in Column 4 is an average price. The shares were purchased in multiple transactions at prices ranging from $14.54 - $14.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (4) to this Form 4.; Dr. Behrenbruch is the sole director and shareholder of Elk River Holdings Pty Ltd.